Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation

Molecular Cancer Therapeutics

Volumn 2, Issue 10, 2003, Pages 1023-1029

  Yang, Hong ^a   Filipovic, Zoran ^a   Brown, David ^b   Breit, Samuel N ^b   Vassilev, Lyubomir T ^a  

^a HOFFMANN LA ROCHE INC   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PLAB PROTEIN; PROTEIN P53; TUMOR MARKER;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANCER TRANSPLANTATION; COLON TUMOR; DOSE RESPONSE; GENETICS; HUMAN; KINETICS; METABOLISM; MOUSE; NUDE MOUSE; POLYMERASE CHAIN REACTION; TIME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2442701601     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Vogelstein B., Lane D., and Levine A. J. Surfing the p53 network. Nature, 408: 307-310, 2000.
2. Hall, P. A. and Lane, D. Tumor suppressors: a developing role for p53? Curr. Biol., 7: 144-147, 1997.
3. Hainaut, P. and Hollstein, M. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res., 77: 81-137, 2000. (Pubitemid 29439303)
4. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997. (Pubitemid 27131374)
5. Kastan, M. B., Canman, C. E., and Leonard, C. J. P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev., 14: 3-15, 1995.
6. Freedman, D. A., Wu, L., and Levine, A. J. Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci., 55: 96-107, 1999. (Pubitemid 29077858)
7. Momand, J., Wu, H. H., and Dasgupta, G. MDM2 - master regulator of the p53 tumor suppressor protein. Gene, 242: 15-29, 2000. (Pubitemid 30064488)
8. Lane, D. P. and Lain, S. Therapeutic exploitation of the p53 pathway. Trends Mol. Med., 8: 38-42, 2002.
9. Foster, B. A., Coffey, H., Morin, M. J., and Rastinejad, F. Pharmacological rescue of mutant p53 conformation and function. Science, 286: 2507-2510, 1999.
10. McCormick, F. Cancer gene therapy: fringe or cutting edge? Nat. Rev. Cancer, 1: 130-141, 2001. (Pubitemid 33741888)
11. Chen, L., Agrawal, S., Zhou, W., Zhang, R., and Chen, J. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc. Natl. Acad. Sci. USA, 95: 195-200, 1998. (Pubitemid 28103930)
12. Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debussche, L., and Wasylyk, B. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53. Oncogene, 18: 1921-1934, 1999. (Pubitemid 29150079)
13. Tortora, G., Caputo, R., Damiano, V., Bianco, R., Chen, J., Agrawal, S., Bianco, A. R., and Ciardiello, F. A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. Int. J. Cancer, 88: 804-809, 2000.
14. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825,1993. (Pubitemid 23346378)
15. El-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W., and Vogelstein, B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994. (Pubitemid 24108052)
16. Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S., Pryor, K., Walsh, B. J., Nicholson, R. C., Fairlie, W. D., Por, S. B., Robbins, J. M., and Breit, S. N., MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. USA, 94: 11514-11519, 1997. (Pubitemid 27451030)
17. Paralkar, V. M., Vail, A. L., Grasser, W. A., Brown, T. A., Xu, H., Vukicevic, S., Ke, H. Z., Qi, H. Owen, T. A., and Thompson, D. D. Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family. J. Biol. Chem., 273: 13760-1367, 1998.
18. Yokoyama-Kobayashi, M., Saeki, M., Sekine, S., and Kato, S. Human cDNA encoding a novel TGF-β superfamily protein highly expressed in placenta. J. Biochem. (Tokyo), 122: 622-626, 1997. (Pubitemid 27443241)
19. Hromas, R., Hufford, M., Sutton, J., Xu, D., Li, Y., and Lu, L. PLAB, a novel placental bone morphogenetic protein. Biochim. Biophys. Acta, 1354: 40-44, 1997. (Pubitemid 27479891)
20. Baek, S. J., Horowitz, J. M., and Eling, T. E. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J. Biol. Chem., 276: 33384-33392, 2001.
21. Tan, M., Wang, Y., Guan, K., and Sun, Y. PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway. Proc. Natl. Acad. Sci. USA, 97: 109-114, 2000. (Pubitemid 30055792)
22. Li, P. X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., and Klamut, H. J. Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem., 275: 20127-20135. 2000. (Pubitemid 30441624)
23. Detmer, K., Steele, T. A., Shoop, M. A., and Dannawi, H. Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines. Blood Cells Mol. Dis., 25: 310-323, 1999. (Pubitemid 30103951)
24. Strelau, J., Sullivan, A., Bottner, M., Lingor, P., Falkenstein, E., Suter-Crazzolara, C., Galter, D., Jaszai, J., Krieglstein, K., and Unsicker, K. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J. Neurosci., 20: 8597-8603, 2000.
25. Krieglstein, K., Strelau, J., Schober, A., Sullivan, A., and Unsicker, K. T. TGF-β and the regulation of neuron survival and death. J. Physiol. (Paris), 96: 25-30, 2002. (Pubitemid 34087030)
26. Albertoni, M., Shaw, P. H., Nozaki, M., Godard, S., Tenan, M., Hamou, M. F., Fairlie, D. W., Breit, S. N., Paralkar, V. M., de Tribolet, N., Van Meir, E. G., and Hegi, M. E. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene, 21: 4212-4219, 2002. (Pubitemid 34753827)
27. Moore, A. G., Brown, D. A., Fairlie, W. D., Bauskin, A. R., Brown, P. K., Munier, M. L. C., Russell, P. K., Salamonsen, L. A., Wallace, E. M., and Breit, S. N. The TGF-β superfamily cytokine MIC-1 is present in high concentrations in the serum of pregnant women. J. Clin. Endocrinol. Metab., 85: 4781-4788, 1999. (Pubitemid 32157666)
28. Brown, D. A., Breit, S. N., Buring, J., Fairlie, W. D., Moore, A. G., Liu, T., and Ridker, P. M. Plasma concentration of macrophage inhibitory cytokine-1 (MIC-1) and the risk of cardiovascular events in women. Lancet, 359: 2159-2163, 2002. (Pubitemid 34694024)
29. Vassilev, L. T., Kazmer, S., Marks, I. M., Pezzoni, G., Sala, F., Mischke, S. G., Foley, L., and Berthel, S. J. Cell-based screening approach for antitumor drug leads which exploits sensitivity differences between normal and cancer cells: identification of two novel cell-cycle inhibitors. Anticancer Drug Res., 16: 7-17, 2001. (Pubitemid 33116830)
30. Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene, 20: 3387-3398, 2001.